Quintrio
Home

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

CapsoVision, Inc. Common Stock

CV

CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.

Last trade $6.57
Day change +$0.095 (+1.47%)
Day range $6.35 – $6.61
Volume 63,929
Market cap $347M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$346.85M
Price / earnings
—
Price / book
13.15×
Price / sales
24.92×
EV / sales
23.35×
EV / EBITDA
-11.23×

Profitability

Earnings per share
-$0.55
Return on assets
-89.3%
Return on equity
-110.91%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
5.07×
Quick ratio
4.29×
Cash ratio
3.55×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$29.28M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CV, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025
Revenue$3.57M$3.64M$2.79M$3.92M$3.54M
Cost of revenue$1.8M$1.77M$1.46M$1.96M$1.62M
Gross profit$1.76M$1.87M$1.33M$1.95M$1.91M
Selling, general and administrative$4.35M$4.14M$3.99M$3.7M$3.84M
Research and development$4.8M$5.31M$4.44M$5.72M$6.09M
Total operating expenses$9.15M$9.45M$8.42M$9.42M$9.93M
Operating income-$7.38M-$7.58M-$7.09M-$7.46M-$8.02M
Interest expense$46K$0$0$0$132K
Income before taxes-$7.34M-$7.48M-$7.03M-$7.37M-$7.92M
Income taxes$0$0$0$24K$0
Net income-$7.34M-$7.48M-$7.03M-$7.39M-$7.92M
Net income attributable to common shareholders-$7.34M-$7.48M-$7.03M-$7.39M-$7.92M
EBITDA-$7.33M-$7.52M-$7.04M-$7.06M-$7.97M
Basic earnings per share-$0.15-$0.15-$0.15-$0.16-$0.17
Diluted earnings per share-$0.15-$0.15-$0.15-$0.16-$0.17

Recent news

Company coverage with links to the original publishers.

Publication times in UTC

No recent company news found.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
May 2, 2012$0.23May 15, 2012unknown
Feb 1, 2012$0.23Feb 15, 2012unknown
Nov 2, 2011$0.23Nov 15, 2011recurring
Aug 3, 2011$0.23Aug 15, 2011recurring
Apr 29, 2011$0.23May 13, 2011unknown

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.